Helping life sciences organizations improve their decision-making, productivity, and impact.
Greater confidence in your future when significant resources are at stake.
We help you assess what's at stake, plan different scenarios, and generate alignment with C-Suite and your Board.
More effective negotiation strategies that maximize the value you capture.
We advise on negotiations with suppliers, licensees, investors, board members, agencies, strategic partners, M&A targets.
Stronger key relationships inside and outside your organization.
We work with you to understand the roots of your relationship challenges, then help you realize their full potential.
Program Management Office
Leadership for your program management, and better results from your projects.
We set-up and manage PMOs to oversee your projects and initiatives, with an emphasis on outcomes not imputs.
Long-term culture and performance improvement across your lines of business.
We run impact assessments, secure stakeholder buy-in, and implement your most important change programs.
Realizing more of your integration thesis by realizing more of its value.
We plan and integrate your acquisitions with an eye to realizing full synergy potential while preserving the best of both cultures.
Supported product strategy for a leading mRNA biotech during Covid-19, playing Chief of Staff across multiple functions and framing strategic trade-offs for management.
Gene Therapy Biotech
Drove the financial forecasting, scenario-generation, and strategic assessment of a $100m+ buy-vs-build question for the CMC team of a rapid-growth CRISPR biotech company.
Set-up and led a PMO for the US manufacturing plant of a global pharma company, improving plant governance and project accountability.
Built a staffing model for a global biotech company in order to more effectively plan cross-functional staff involvement.
Consumer Genetics Startup
Revamped the business model and investor strategy for a genetics startup so it could focus on a significantly larger target market in a more cost-effective way.
Jeffrey Hugh Christiansen
Jeff is a former Bain & Company consultant with a passion for advising on negotiations, and managing complex projects, in the life sciences. He founded ValCap Life Sciences in 2019.
Over the past 16 years, he has worked across four continents in a range of capacities, from private equity investing and capacity-building to project management and large-scale change programs. Since 2006, he has taught courses, led workshops, and advised on negotiations.
His negotiation advisory is based on ideas developed at the Program on Negotiation -- a consortium of Harvard, MIT, and Tufts and a pioneer in interdisciplinary thinking on negotiation strategy since 1983 -- as well as his broad industry and geographic experience.
During the Covid-19 pandemic, he worked with world-shaping organizations to support the development and commercialization of the mRNA vaccine, along the way developing an even deeper appreciation for how innovation -- and effective execution -- can deliver amazing results.
He is also an investor in -- and an occasional advisor to -- select early-stage life sciences companies.
Jeff studied at Washington University in St. Louis, Georgetown, and Oxford, and currently resides in New York City.